BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26846978)

  • 1. Antitumor effects of galectin-3 inhibition in human renal carcinoma cells.
    Xu Y; Li C; Sun J; Li J; Gu X; Xu W
    Exp Biol Med (Maywood); 2016 Jul; 241(13):1365-73. PubMed ID: 26846978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.
    Ping JG; Wang F; Pu JX; Hou PF; Chen YS; Bai J; Zheng JN
    Tumour Biol; 2016 Sep; 37(9):12823-12831. PubMed ID: 27449035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma.
    Huang CS; Tang SJ; Lee MH; Chang Wang CC; Sun GH; Sun KH
    J Cell Mol Med; 2018 Dec; 22(12):5909-5918. PubMed ID: 30246456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
    Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
    Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of galectin-3 in pituitary tumors.
    Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
    Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Numb suppresses growth, migration, and invasion of human clear cell renal cell carcinoma cells.
    Sima J; Zhang B; Yu Y; Sima X; Mao Y
    Tumour Biol; 2015 Apr; 36(4):2885-92. PubMed ID: 25480416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of novel compound, guttiferone K, on colon cancer by p21Waf1/Cip1-mediated G(0) /G(1) cell cycle arrest and apoptosis.
    Kan WL; Yin C; Xu HX; Xu G; To KK; Cho CH; Rudd JA; Lin G
    Int J Cancer; 2013 Feb; 132(3):707-16. PubMed ID: 22733377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest.
    Kobayashi K; Morishita A; Iwama H; Fujita K; Okura R; Fujihara S; Yamashita T; Fujimori T; Kato K; Kamada H; Niki T; Hirashima M; Okano K; Suzuki Y; Masaki T
    Oncol Rep; 2015 Oct; 34(4):1761-70. PubMed ID: 26260906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.
    Zheng D; Hu Z; He F; Gao C; Xu L; Zou H; Wu Z; Jiang X; Wang J
    Oncol Rep; 2014 Jul; 32(1):411-8. PubMed ID: 24807674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells.
    Metz C; Döger R; Riquelme E; Cortés P; Holmes C; Shaughnessy R; Oyanadel C; Grabowski C; González A; Soza A
    Biol Res; 2016 Jul; 49(1):33. PubMed ID: 27459991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells.
    Qiao L; Liang N; Xie J; Luo H; Zhang J; Deng G; Li Y; Zhang J
    Mol Med Rep; 2016 Jan; 13(1):160-6. PubMed ID: 26718452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY; Yao AM; Chang XN; Guo YH; Xu R
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
    Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B
    Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
    Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA
    Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective suppression of Notch1 inhibits proliferation of renal cell carcinoma cells through JNK/p38 pathway.
    Wu K; Hu L; Hou J
    Oncol Rep; 2016 May; 35(5):2795-800. PubMed ID: 26986634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells.
    Fan L; Ma Y; Liu Y; Zheng D; Huang G
    Eur J Pharmacol; 2014 Nov; 743():79-88. PubMed ID: 25242120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.
    Wu J; Li L; Jiang G; Zhan H; Wang N
    Int J Oncol; 2016 Dec; 49(6):2471-2479. PubMed ID: 27748795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression.
    Wang L; Wang G; Yang D; Guo X; Xu Y; Feng B; Kang J
    Mol Med Rep; 2013 Oct; 8(4):1279-85. PubMed ID: 23969579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.